$3.61
-0.11 (-2.96%)
Open$3.70
Previous Close$3.72
Day High$3.71
Day Low$3.55
52W High$5.47
52W Low$3.23
Volume—
Avg Volume210.2K
Market Cap1.82B
P/E Ratio18.45
EPS$0.18
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+727.7% upside
Current
$3.61
$3.61
Target
$29.88
$29.88
$20.40
$29.88 avg
$34.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 197.82M | 169.31M | 608.59M |
| Net Income | -12,729,451 | -9,805,294 | 77.66M |
| Profit Margin | -6.4% | -6.1% | 12.8% |
| EBITDA | -20,594,803 | -16,745,175 | 120.12M |
| Free Cash Flow | — | — | 67.66M |
| Rev Growth | +16.8% | +16.8% | +15.9% |
| Debt/Equity | — | — | 0.80 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |